EPIC Act of 2025

Sponsored bySen. Tillis, Thomas [R-NC]NC· Introduced 4 mars 2025

Open on Congress.gov

Cosponsors

Actions

Amendments

Committees

—

Since introduced

Introduced

Committee

Passed Chamber

Passed Both

Enacted

Step 1 of 0

Latest action

Read twice and referred to the Committee on Finance.

4 mars 2025·1 year ago

Summary

Introduced in Senate · Updated 13 février 2026

Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025

This bill lengthens the amount of time for which drug products must have market approval in order for the products to qualify for negotiation under the Medicare Drug Price Negotiation Program.

The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.

The bill modifies these provisions so as to require drug products to also have had at least 11 years of market approval in order to qualify for negotiation beginning in 2028.

Timeline

2 actions

Read twice and referred to the Committee on Finance.
4 mars 2025 · IntroReferral
Introduced in Senate
4 mars 2025 · IntroReferral

Sponsorship

7 cosponsors

Sponsor

Sen. Tillis, Thomas [R-NC]NC

Cosponsors

Republican7100%

Republican:Sen. Marshall, Roger [R-KS]KS
Republican:Sen. Banks, Jim [R-IN]IN
Republican:Sen. Curtis, John R. [R-UT]UT
Republican:Sen. Budd, Ted [R-NC]NC
Republican:Sen. Blackburn, Marsha [R-TN]TN
Republican:Sen. Lankford, James [R-OK]OK
Republican:Sen. Daines, Steve [R-MT]MT

Classification

Policy area

Health

Cosponsor momentum

Cumulative over time

Track EPIC Act of 2025 as it moves through Congress